GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.

MLA

Thamm, Douglas H., et al. “GS-9219/VDC-1101--a Prodrug of the Acyclic Nucleotide PMEG Has Antitumor Activity in Spontaneous Canine Multiple Myeloma.” BMC Veterinary Research, vol. 10, Jan. 2014, p. 30. EBSCOhost, https://doi.org/10.1186/1746-6148-10-30.

APA

Thamm, D. H., Vail, D. M., Kurzman, I. D., Babusis, D., Ray, A. S., Sousa-Powers, N., & Tumas, D. B. (2014). GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma. BMC Veterinary Research, 10, 30. https://doi.org/10.1186/1746-6148-10-30

Chicago

Thamm, Douglas H, David M Vail, Ilene D Kurzman, Darius Babusis, Adrian S Ray, Noel Sousa-Powers, and Daniel B Tumas. 2014. “GS-9219/VDC-1101--a Prodrug of the Acyclic Nucleotide PMEG Has Antitumor Activity in Spontaneous Canine Multiple Myeloma.” BMC Veterinary Research 10 (January): 30. doi:10.1186/1746-6148-10-30.